U.S. Markets close in 3 hrs 48 mins

(MRK,NVS,PFE)


. Currency in USD
Add to watchlist
Full screen
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Novartis AG :NVS-US: Earnings Analysis: Q2, 2017 By the Numbers : July 20, 2017
    Capital Cube41 minutes ago

    Novartis AG :NVS-US: Earnings Analysis: Q2, 2017 By the Numbers : July 20, 2017

    Categories: Yahoo FinanceGet free summary analysis Novartis AG reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Novartis AG – Johnson & Johnson (JNJ-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 12,462.71 million, Net Earnings of USD 2,015.70 million. Gross ... Read more (Read more...)

  • Tesla Started At Neutral, High Risk; Amazon Gets Price Target Hike
    Investor's Business Daily3 hours ago

    Tesla Started At Neutral, High Risk; Amazon Gets Price Target Hike

    Citigroup on Thursday initiated coverage of electric car maker Tesla at neutral/high risk. Analysts also upgraded PC and printer maker HP and athletic apparel vendor Nike.

  • Barrons.com3 hours ago

    Pfizer: We Still Like You But…

    Shares of Pfizer (PFE) have gained 5.1% since closing at $32 on June 7, and the stock even looks like it had been making a run for the top of its recent range. In fact, they call themselves "long-time supporters" of the company, and see "opportunities for upside over the long term." So why are they downgrading Pfizer?